HeyJaredOlivia Long
- Indexed articles, last 90 days
- 32
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Selectscience
- Top 5M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
OPM expands CHO biosimilar platform - SelectScience news (opens the original)
Read excerpt
OPM Biosciences has launched the Biosimilar Media Optimization Service and Sureness™ Biosimilar Platform. The offerings extend the company’s OPM-CHO platform to help biosimilar developers improve productivity, align critical quality attributes (CQAs) with reference biologics, maintain process knowledge, and advance programs from cell line development through commercial manufacturing and regulatory support. Cell culture media can significantly influence cell growth, productivity, and CQAs, making
Beyond bioassay validation - SelectScience interview (opens the original)
Read excerpt
For decades, bioassay validation has functioned as a kind of graduation ceremony. A bioassay is developed, qualified, tested against defined criteria, and once it clears that bar, transferred into a regulated laboratory for routine use. The assumption is simple: if assay performance is proven during validation, it will remain fit for purpose throughout the lifecycle of a biologic. Increasingly, however, scientists are discovering that long-term assay performance cannot be taken for granted. That
New CO analyzer measures complex gases - SelectScience news (opens the original)
Read excerpt
Hiden Analytical has announced the availability of its Carbon Monoxide Analyzer, developed to provide continuous, quantitative carbon monoxide (CO) measurement in complex gas mixtures. Designed for integration with Hiden mass spectrometry systems, the analyzer supports researchers worldwide studying syngas, biogas, catalysis and related gas-conversion processes by measuring CO while other gaseous components are monitored simultaneously. The CO Analyzer integrates with Hiden HPR-20 and QGA 2.0 Ga
New Cas9 mRNA advances CRISPR editing - SelectScience news (opens the original)
Read excerpt
Danaher companies Integrated DNA Technologies (IDT) and Aldevron, have launched research-grade S.p. Cas9 mRNA in wild-type and SpyFi™ high-fidelity formats. The offering is available to researchers and therapeutic developers for CRISPR-based genome editing workflows, providing performance, format flexibility and manufacturing continuity to help advanced gene editing programs progress from research toward development with greater confidence. The co-developed offering combines IDT’s CRISPR protein
De-risk drug candidates early - SelectScience interview (opens the original)
Read excerpt
It is well understood in drug development that failures get more expensive the later they happen. Yet many candidates are not evaluated early enough to inform critical go/no-go decisions or reveal risks that could derail development later. A safety signal missed until a Good Laboratory Practice (GLP) toxicology study, or worse, until the clinic, costs far more to address than the same signal caught before a candidate is ever committed to development. That gap, between a liability caught early an
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Selectscience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.